Hypermethylation of RASSF1A, CCDN2, HIN1 and APC correlates mainly with HR+ breast cancer, whereas hypermethylation of CDH1 and CDH13 is more frequent in TNBC patients (77). Here, RASSF1 is linked to breast carcinoma.